Navigating Change: OSHA’s 2024 Wrap-Up and a Look Ahead to 2025
In the latest episode of Greenberg Traurig’s Workplace Safety Review podcast, co-hosts Adam Roseman and Joshua Bernstein provide a comprehensive wrap-up of the significant OSHA developments from 2024 and explore what’s on the horizon for 2025. They delve into the impacts of administrative changes, including the Supreme Court’s Loper Bright decision, which overturned Chevron deference, and how it may affect OSHA litigation.
Their discussion highlights key regulatory updates, like the proposed heat stress and lockout/tagout standards, and examines the potential implications of the Kenrick Steel case challenging the constitutionality of the Occupational Safety and Health Review Commission.
As the Trump administration prepares to take office, the hosts consider the prospective leadership and policy direction under Secretary of Labor nominee Lori Chavez-DeRemer and the next OSHA head.
HHS OCR Proposes Significant Modifications to HIPAA Security Rule
Overview
The US Department of Health and Human Services (HHS) Office for Civil Rights (OCR) announced on December 27, 2024, and published in the Federal Register on January 6, 2025, a Notice of Proposed Rulemaking (NPRM) proposing extensive modifications to the HIPAA Security Rule. If finalized, these would be the first modifications of the Security Rule since 2013 and could entail significant additional compliance obligations and costs for HIPAA covered entities and business associates (collectively, regulated entities). For reference, a redline of the existing language of the Security Rule with the NPRM’s proposed modifications is available here.
READ FULL REPORT
Life Science Dealmaking Trends 2025
In this series of videos, International Chair of Life Sciences Cheryl Reicin provides valuable insights on a number of trends she is seeing in Big Pharma dealmaking and M&A. She discusses 2025 deal trends, M&A drivers, patent cliff impacts, and the hottest emerging sectors.
Drivers of Big Pharma M&A
Big Pharma Patent Cliff Impacts to M&A
What are the Hottest Sectors in the Life Science Industry?
Central Nervous System (CNS) Investment Opportunities
How Do You See Big Pharmas in AI?